A detailed history of Us Bancorp \De\ transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 2,985 shares of SRRK stock, worth $131,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,985
Previous 3,379 11.66%
Holding current value
$131,220
Previous $28,000 17.86%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$7.63 - $9.71 $3,006 - $3,825
-394 Reduced 11.66%
2,985 $23,000
Q2 2024

Aug 06, 2024

SELL
$7.84 - $16.79 $34,064 - $72,952
-4,345 Reduced 56.25%
3,379 $28,000
Q1 2024

May 07, 2024

BUY
$13.2 - $17.76 $28,604 - $38,485
2,167 Added 39.0%
7,724 $137,000
Q4 2023

Feb 09, 2024

BUY
$6.52 - $20.32 $36,231 - $112,918
5,557 New
5,557 $104,000
Q2 2023

Aug 09, 2023

SELL
$5.79 - $9.11 $1,215 - $1,913
-210 Reduced 68.4%
97 $0
Q4 2022

Feb 13, 2023

SELL
$7.02 - $9.76 $1,235 - $1,717
-176 Reduced 36.44%
307 $2,000
Q3 2022

Oct 27, 2022

BUY
$5.33 - $11.3 $2,574 - $5,457
483 New
483 $3,000
Q2 2022

Aug 01, 2022

SELL
$4.66 - $13.96 $3,350 - $10,037
-719 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$11.89 - $24.68 $6,991 - $14,511
588 Added 448.85%
719 $9,000
Q4 2021

Feb 11, 2022

SELL
$24.14 - $35.18 $627 - $914
-26 Reduced 16.56%
131 $3,000
Q3 2021

Nov 10, 2021

SELL
$27.38 - $42.21 $5,174 - $7,977
-189 Reduced 54.62%
157 $5,000
Q2 2021

Aug 05, 2021

SELL
$26.34 - $46.62 $6,769 - $11,981
-257 Reduced 42.62%
346 $10,000
Q1 2021

Apr 28, 2021

BUY
$45.96 - $68.02 $12,730 - $18,841
277 Added 84.97%
603 $30,000
Q4 2020

Feb 04, 2021

BUY
$13.72 - $51.57 $3,169 - $11,912
231 Added 243.16%
326 $16,000
Q3 2020

Nov 10, 2020

BUY
$10.54 - $18.47 $337 - $591
32 Added 50.79%
95 $2,000
Q2 2020

Aug 07, 2020

BUY
$10.37 - $20.64 $653 - $1,300
63 New
63 $1,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.27B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.